ArticleCureus2025
Shamanic Kambô Frog Hyponatremic Toxicity Leading to Brain Death: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The South American shamanic Kambô ritual involves applying the skin secretions of Phyllomedusa bicolor (giant monkey frog) to superficial burns for purported spiritual and therapeutic benefits. These secretions contain a complex mix of bioactive peptides, such as phyllocaerulein, phyllomedusin, phyllokinin, sauvagine, dermorphins, and deltorphins, that interact with diverse neurotransmitter and hormone receptor systems. Specifically, these peptides engage cholecystokinin (CCK) receptors, neurokinin-1 (NK1) receptors, bradykinin B2 receptors, corticotropin-releasing factor (CRF) receptors, and opioid receptors (μ and δ subtypes), influencing gastrointestinal, cardiovascular, endocrine, and neurologic pathways. While often short-lived, these peptides provoke profound physiological disturbances, including violent emesis, vasodilation, fluid shifts, and antidiuretic hormone (ADH) dysregulation. The combination of these effects with ritualistic overhydration of water can trigger life-threatening hyponatremia, cerebral edema, and ultimately, brain death. We present the first documented case of brain death associated with Kambô toxicity. A 35-year-old female developed headache, emesis, and unilateral fixed and dilated pupil within hours of a Kambô ritual. Imaging demonstrated diffuse cerebral edema and loss of intracranial blood flow. Laboratory workup revealed severe hyponatremia, likely due to excessive water intake, peptide-induced emesis with sodium loss, and suspected SIADH. Despite aggressive medical management, the patient progressed to brain death. Kambô rituals are unregulated and increasingly practiced in Western countries despite a lack of medical oversight. The ritual's unique combination of cutaneous toxin delivery, extreme emesis, and excessive water hydration creates a perfect storm for acute symptomatic hyponatremia and cerebral herniation. Physicians should consider Kambô exposure in patients presenting with acute neurologic decline and dot-like burn patterns. Public awareness, clinician education, and the development of treatment algorithms are critical as the use of this neurotoxic ritual continues to expand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.